The call ran from 3:02 PM to 3:55 PM IST (53 min).
Key takeaways
Q2 FY27 revenue ₹83.1 Cr (+17%), PAT ₹4.86 Cr (+26%), EBITDA margin 21.6%. The FY27 ₹420–430 Cr target needs a steep H2 ramp the Q2 run-rate doesn't support.
| Management target | Revenue 20.0% |
|---|
| Revenue growth | Q2 revenue +17% YoY to ₹83.1 Cr; H1 +12%. |
|---|---|
| Margins | Q2 EBITDA 21.6%; 25%+ two-year aim; polymer costs volatile. |
| Demand visibility | Steriport demand strong in ICU and critical care; SVP demand unquantified. |
| Management confidence | Over-optimistic: bold targets, deflects on SVP numbers. |
Growth
Q2 revenue +17%, EBITDA +22%. H1 revenue +12% but EBITDA only +8%, so the quality story weakens.
Outlook
FY27 revenue ₹420–430 Cr. SVP ₹16 Cr in FY28. Two-year aim: 20%+ revenue CAGR, 25%+ EBITDA margin.
Risks
FY27 ₹420–430 Cr needs ~₹270 Cr in H2 versus ~₹83 Cr quarterly run-rate. SVP line slipped to Q1 FY28.
Last quarter's promises, checked
Delivered
- Q2 rev 'needle may not move much' (Q1 ₹69 Cr) → ₹83.1 Cr, +17% YoY (= BEAT)
Partly delivered
- SteriPort L3 live 24–25 Aug → live Sep 2026 (= PARTIAL)
- Debt ₹30–35 Cr/yr cut → ₹35 Cr/yr planned, actual unreported (= PARTIAL)
Missed
- Console margin +4–5% post Line 3 → Q2 EBITDA 21.6% vs Q1 ~22%, no expansion (= MISS)
- SVP live Q4 FY27 → slipped to Q1 FY28 (= MISS)
- D/E falling from 1.06 → 1.1x (= MISS)
Summary by ALFA Finder, written with AI assistance from our own recording of the call, published . Open it on ALFA Filings ›
The results behind this call
Amanta Healthcare Q2 FY27 Results: Net Profit ₹4.9 Cr, Up 308.3% YoY
Amanta Healthcare Ltd reported revenue from operations of ₹83.1 Cr (+17.2% YoY) and net profit of ₹4.9 Cr (+308.3% YoY) for Q2 FY27.
- Key figure
- Net profit ₹4.9 Cr · +308.3% YoY
What management said last time
Full summary →From the call summary published .
Outlook they gave
EBITDA margins guided to expand from 22% to 25% following Steriport expansion and solar project commissioning.
Growth they described
Revenue grew 5% YoY to 288Cr, while PAT surged 42% supported by better operating leverage and debt refinancing.
Call details
| Company | Amanta Healthcare Ltd |
|---|---|
| NSE symbol | AMANTA |
| ISIN | INE084K01015 |
| Call | Q2 FY27 earnings call |
| Date | Wednesday, 4 November 2026 |
| Time | 3:00 PM IST |
| Length | 53 min |
| Audio | Our stream on YouTube ↗ |
Amanta Healthcare Ltd: key numbers
- Share price
- ₹185.80
- Market cap
- ₹721.5 Cr
- Revenue (annual)
- ₹287.7 Cr
- Net profit (annual)
- ₹14.88 Cr
- P/E (TTM)
- 39.4×Sector 41.3×
- Promoter holding
- 63.80%+0.00% QoQ
- FII holding
- 0.07%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Other calls on Wed, 4 Nov
Today's concalls →
